ELLESTE SOLO 1MG TABLETS
Active substance(s): ESTRADIOL HEMIHYDRATE / ESTRADIOL HEMIHYDRATE / ESTRADIOL HEMIHYDRATE
Elleste SoloTM 1 mg and 2 mg Tablets
1 mg and 2 mg film-coated tablets
Read all of this leaflet carefully before you start
taking this medicine because it contains important
information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or
• This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even
if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor
or pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
What is in this leaflet
1. What Elleste Solo is and what it is used for
2. What you need to know before you take Elleste Solo
3. How to take Elleste Solo
4. Possible side effects
5. How to store Elleste Solo
6. Contents of the pack and other information
1. WHAT ELLESTE SOLO IS AND WHAT IT
IS USED FOR
Elleste Solo is a Hormone Replacement Therapy
(HRT). It contains the female hormone oestrogen
Elleste Solo is used for:
Relief of symptoms occurring after menopause
During the menopause, the amount of the oestrogen
produced by a woman’s body drops. This can cause
symptoms such as hot face, neck and chest ("hot
flushes"). Elleste Solo alleviates these symptoms after
menopause. You will only be prescribed Elleste Solo if
your symptoms seriously hinder your daily life.
Prevention of osteoporosis
After the menopause some women may develop
fragile bones (osteoporosis). You should discuss all
available options with your doctor.
If you are at an increased risk of fractures due to
osteoporosis and other medicines are not suitable for
you, you can use Elleste Solo 2 mg to prevent
osteoporosis after menopause.
2. WHAT YOU NEED TO KNOW BEFORE
YOU TAKE ELLESTE SOLO
Medical history and regular check-ups
The use of HRT carries risks which need to be
considered when deciding whether to start taking it, or
whether to carry on taking it.
The experience in treating women with a premature
menopause (due to ovarian failure or surgery) is
limited. If you have a premature menopause the risks
of using HRT may be different. Please talk to your
Before you start (or restart) HRT, your doctor will ask
about your own and your family’s medical history.
Your doctor may decide to perform a physical
examination. This may include an examination of your
breasts and/or an internal examination, if necessary.
Once you have started on Elleste Solo you should see
your doctor for regular check-ups (at least once a
year). At these check-ups, discuss with your doctor the
benefits and risks of continuing with Elleste Solo.
Go for regular breast screening, as recommended by
Do not take Elleste Solo
if any of the following applies to you. If you are not
sure about any of the points below, talk to your doctor
before taking Elleste Solo,
Do not take Elleste Solo
• If you have or have ever had breast cancer, or if
you are suspected of having it
• If you have cancer which is sensitive to oestrogens,
such as cancer of the womb lining (endometrium),
or if you are suspected of having it
• If you have any unexplained vaginal bleeding
• If you have excessive thickening of the womb
lining (endometrial hyperplasia) that is not being
• If you have or have ever had a blood clot in a vein
(thrombosis), such as in the legs (deep venous
thrombosis) or the lungs (pulmonary embolism)
• If you have a blood clotting disorder (such as
protein C, protein S, or antithrombin deficiency)
• If you have or recently have had a disease caused by
blood clots in the arteries, such as a heart attack,
stroke or angina
• If you have or have ever had a liver disease and
your liver function tests have not returned to normal
• If you have a rare blood problem called “porphyria”
which is passed down in families (inherited)
• If you are allergic to estradiol hemihydrate or any
of the other ingredients of this medicine (listed in
If any of the above conditions appear for the first time
while taking Elleste Solo, stop taking it at once and
consult your doctor immediately.
When to take special care with Elleste Solo
Tell your doctor if you have ever had any of the
following problems, before you start the treatment, as
these may return or become worse during treatment
with Elleste Solo. If so, you should see your doctor
more often for check-ups:
• fibroids inside your womb
• growth of womb lining outside your womb
(endometriosis) or a history of excessive growth of
the womb lining (endometrial hyperplasia)
• increased risk of developing blood clots
(see “Blood clots in a vein (thrombosis)”)
• increased risk of getting an oestrogen-sensitive cancer
(such as having a mother, sister or grandmother who
has had breast cancer)
• high blood pressure
• a liver disorder, such as a benign liver tumour
• migraine or severe headaches
• a disease of the immune system that affects many
organs of the body (systemic lupus erythematosus,
• a disease affecting the eardrum and hearing
• a very high level of fat in your blood (triglycerides)
• fluid retention due to cardiac or kidney problems
Stop taking Elleste Solo and see a doctor
If you notice any of the following when taking HRT:
• any of the conditions mentioned in the ‘DO NOT
take Elleste Solo’ section
• yellowing of your skin or the whites of your eyes
(jaundice). These may be signs of a liver disease
• a large rise in your blood pressure (symptoms may
be headache, tiredness, dizziness)
• migraine-like headaches which happen for the first
• if you become pregnant
• if you notice signs of a blood clot, such as:
• painful swelling and redness of the legs
• sudden chest pain
• difficulty in breathing
For more information, see ‘Blood clots in a vein
Note: Elleste Solo is not a contraceptive. If it is less
than 12 months since your last menstrual period or
you are under 50 years old, you may still need to use
additional contraception to prevent pregnancy. Speak
to your doctor for advice.
HRT and cancer
Excessive thickening of the lining of the womb
(endometrial hyperplasia) and cancer of the lining
of the womb (endometrial cancer)
Taking oestrogen-only HRT will increase the risk of
excessive thickening of the lining of the womb
(endometrial hyperplasia) and cancer of the womb
lining (endometrial cancer).
Taking a progestogen in addition to the oestrogen for
at least 12 days of each 28 day cycle protects you from
this extra risk. So your doctor will prescribe a
progestogen separately if you still have your womb. If
you have had your womb removed (a hysterectomy),
discuss with your doctor whether you can safely take
this product without a progestogen.
In women who still have a womb and who are not
taking HRT, on average, 5 in 1000 will be diagnosed
with endometrial cancer between the ages of 50 and 65.
For women aged 50 to 65 who still have a womb and
who take oestrogen-only HRT, between 10 and 60
women in 1000 will be diagnosed with endometrial
cancer (i.e. between 5 and 55 extra cases), depending
on the dose and for how long it is taken.
Evidence suggests that taking combined oestrogen-progestogen and possibly also oestrogen-only
HRT increases the risk of breast cancer. The extra risk
depends on how long you take HRT. The additional
risk becomes clear within a few years. However, it
returns to normal within a few years (at most 5) after
For women who have had their womb removed and
who are using oestrogen-only HRT for 5 years, little or
no increase in breast cancer risk is shown.
Women aged 50 to 79 who are not taking HRT, on
average, 9 to 17 in 1000 will be diagnosed with breast
cancer over a 5-year period. For women aged 50 to 79
who are taking oestrogen-progestogen HRT over 5
years, there will be 13 to 23 cases in 1000 users (i.e.
an extra 4 to 6 cases).
• Regularly check your breasts. See your doctor if
you notice any changes such as:
• dimpling of the skin
• changes in the nipple
• any lumps you can see or feel
Additionally, you are advised to join mammography
screening programs when offered to you. For
mammogram screening, it is important that you
inform the nurse/healthcare professional who is
actually taking the x-ray that you use HRT, as this
medication may increase the density of your breasts
which may affect the outcome of the mammogram.
Where the density of the breast is increased,
mammography may not detect all lumps.
Ovarian cancer is rare - much rarer than breast cancer.
The use of oestrogen-only or combined oestrogen-progestagen HRT has been associated with a slightly
increased risk of ovarian cancer.
The risk of ovarian cancer varies with age. For
example, in women aged 50 to 54 who are not taking
HRT, about 2 women in 2000 will be diagnosed with
ovarian cancer over a 5-year period. For women who
have been taking HRT for 5 years, there will be about
3 cases per 2000 users (i.e. about 1 extra case).
Effect of HRT on heart and circulation
Blood clots in a vein (thrombosis)
The risk of blood clots in the veins is about 1.3 to
3- times higher in HRT users than in non-users,
especially during the first year of taking it.
Blood clots can be serious, and if one travels to the
lungs, it can cause chest pain, breathlessness, fainting
or even death.
You are more likely to get a blood clot in your veins as
you get older and if any of the following applies to
you. Inform your doctor if any of these situations
applies to you:
• you are unable to walk for a long time because of
major surgery, injury or illness (see also section 3,
If you need to have surgery)
• you are seriously overweight (BMI >30 kg/m2)
• you have any blood clotting problem that needs
long-term treatment with a medicine used to prevent
• if any of your close relatives has ever had a blood
clot in the leg, lung or another organ
• you have systemic lupus erythematosus (SLE)
• you have cancer
For signs of a blood clot, see “Stop taking Elleste Solo
and see a doctor immediately”.
Looking at women in their 50s who are not taking
HRT, on average, over a 5-year period, 4 to 7 in 1000
would be expected to get a blood clot in a vein.
For women in their 50s who have been taking
oestrogen-progestogen HRT for over 5 years, there will
be 9 to 12 cases in 1000 users (i.e. an extra 5 cases).
For women in their 50s who have had their womb
removed and have been taking oestrogen-only HRT for
over 5 years, there will be 5 to 8 cases in 1000 users
(i.e. 1 extra case).
Heart disease (heart attack)
There is no evidence that HRT will prevent a heart
Women over the age of 60 years who use oestrogen-progestogen HRT are slightly more likely to
develop heart disease than those not taking any HRT.
For women who have had their womb removed and are
taking oestrogen-only therapy there is no increased
risk of developing a heart disease.
The risk of getting stroke is about 1.5 times higher in
HRT users than in non-users. The number of extra
cases of stroke due to use of HRT will increase with
Looking at women in their 50s who are not taking
HRT, on average, 8 in 1000 would be expected to have
a stroke over a 5-year period. For women in their 50s
who are taking HRT, there will be 11 cases in 1000
users, over 5 years (i.e. an extra 3 cases).
• HRT will not prevent memory loss. There is some
evidence of a higher risk of memory loss in women
who start using HRT after the age of 65. Speak to
your doctor for advice.
Do not give this medicine to children.
Other medicines and Elleste Solo
Some medicines may interfere with the effect of
Elleste Solo. This might lead to irregular bleeding.
This applies to the following medicines:
• Medicines for epilepsy (such as phenobarbital,
phenytoin and carbamazepin)
• Medicines for tuberculosis (such as rifampicin,
• Medicines for HIV infection (such as nevirapine,
efavirenz, ritonavir and nelfinavir)
• Herbal remedies containing St John’s Wort
Please tell your doctor or pharmacist if you are taking
or have recently taken any other medicines including
medicines obtained without a prescription, herbal
medicines or other natural products.
Pregnancy and breast-feeding
Elleste Solo is for use in postmenopausal women only.
If you become pregnant, stop taking Elleste Solo and
contact your doctor.
Driving and using machines
No effects on driving or using machinery have been
observed for Elleste Solo.
Elleste Solo 2 mg contains Sunset yellow colouring
which can cause allergic-type reactions, including
asthma. This allergy is more common in people who
are allergic to aspirin.
Elleste Solo contains lactose
If you have been told by your doctor that you have an
intolerance to some sugars, contact your doctor before
taking this medicinal product.
3. HOW TO TAKE ELLESTE SOLO
Always take this medicine exactly as your doctor or
pharmacist has told you. Check with your doctor or
pharmacist if you are not sure.
Your doctor will aim to prescribe the lowest dose to
treat your symptoms for as short a time as necessary.
Speak to your doctor if you think this dose is too
strong or not strong enough.
If you are still having regular periods, take your first
tablet on the first day of bleeding.
If you are not having regular periods, you can start
• Take one tablet each day. You can take the tablet at a
time of the day that suits you. But it is best to take it
about the same time each day.
• Swallow the tablets whole, with some water.
• Follow the direction of the arrows on the pack and
take a tablet each day until the pack is empty. All the
tablets are the same.
• The days of the week are marked on the strip to help
you to remember to take one each day.
• When you finish a foil strip, start a new strip on the
Changing from another type of HRT
If you are changing from another type of HRT, start
taking Elleste Solo when you finish the pack of HRT
you are taking at the moment.
If your doctor gives you instructions on changing from
another type of HRT you should follow these
instructions. If you have any doubts you should
contact your doctor.
Will I have periods?
If you have not had a hysterectomy, and you are also
taking a progestogen, you will probably have a
monthly bleed. In the first few months you may get
irregular bleeding. However, if this carries on you
should tell your doctor.
If you need to have surgery
If you are going to have surgery, tell the surgeon that
you are taking Elleste Solo. You may need to stop
taking Elleste Solo about 4 to 6 weeks before the
operation to reduce the risk of a blood clot (see
section 2, Blood clots in a vein). Ask your doctor
when you can start taking Elleste Solo again.
Rare: loss of hair from the scalp, increase in body and
facial hair, itchiness, rashes.
The following side effects have been reported with
• various skin disorders
- discolouration of the skin especially of the face or
neck known as “pregnancy patches” (chloasma)
- painful reddish skin nodules (erythema nodosum)
- rash with target-shaped reddening or sores
Reporting of side effects
If you get any side effects, talk to your doctor,
pharmacist or nurse. This includes any possible side
effects not listed in this leaflet. You can also report
side effects directly via the Yellow Card Scheme at:
By reporting side effects you can help provide more
information on the safety of this medicine.
5. HOW TO STORE ELLESTE SOLO
Keep this medicine out of the sight and reach of
Do not store above 25°C. Store in the original package.
Do not use this medicine after the expiry date which is
stated on the carton after “EXP”. The expiry date
refers to the last day of that month.
Do not throw away any medicines via wastewater or
household waste. Ask your pharmacist to throw away
medicines you no longer use. These measures will
help protect the environment.
6. CONTENTS OF THE PACK AND OTHER
What Elleste Solo contains
• Elleste Solo 1 mg Tablets contain the active
substance 1 milligram estradiol (as hemihydrate).
• Elleste Solo 2 mg Tablets contain the active
substance 2 milligrams estradiol (as hemihydrate).
(The estradiol hemihydrate used to make Elleste Solo
does not come from animals).
• The tablets also contain: lactose monohydrate,
maize starch, povidone, talc, magnesium stearate,
macrogol 400, titanium dioxide (E171), and
• Elleste Solo 2 mg has the extra ingredient sunset
yellow (E110) (see also the warning at the end of
What Elleste Solo looks like and contents of the
Elleste Solo 1 mg Tablets are white film-coated tablets
with an embossing.
Elleste Solo 2 mg Tablets are orange film-coated
tablets with an embossing.
They are supplied in packs containing blister strips of
20, 28, 60, 84 or 100 tablets.
Not all packs sizes may be marketed.
Marketing Authorisation Holder
Meda Pharmaceuticals Ltd, Skyway House,
Parsonage Road, Takeley, Bishop’s Stortford,
CM22 6PU, UK.
Piramal Healthcare (UK) Ltd.
Whalton Road, Morpeth, Northumberland,
NE61 3YA, UK
This medicinal product is authorised in the Member
States of the EEA under the following names:
Parapanol 1 mg and Parapanol 2 mg
Elleste Solo 1 mg Tablets and
Elleste Solo 2 mg Tablets
This leaflet was last revised in 02/2016.
If you forget to take Elleste Solo
Take the tablet as soon as you remember, and take the
next one at the normal time.
If you have missed your tablet by more than 12 hours,
dispose of this tablet safely and take the next one at the
normal time. Do not take a double dose to make up for
the forgotten tablet. If you have not had a hyste-rectomy you may experience breakthrough bleeding or
If you take more Elleste Solo than you should
There should be no problems, but you may feel sick or
actually be sick. If you are worried contact your
doctor. Take the usual tablet the following day.
If you have any further questions on the use of this
medicine, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, this medicine can cause side
effects, although not everybody gets them.
The following diseases are reported more often in
women using HRT compared to women not using
• breast cancer
• abnormal growth or cancer of the lining of the
womb (endometrial hyperplasia or cancer)
• ovarian cancer
• blood clots in the veins of the legs or lungs (venous
• heart disease
• probable memory loss if HRT is started over the age
For more information about these side effects, see
The following side effects have been associated with
Elleste Solo. Frequencies are defined as follows:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Not known: frequency cannot be estimated from the
Common: feeling sick, stomach cramps, headache, an
increase in size of fibroids in the womb, breakthrough
bleeding, changes in weight, oedema (swelling) of
legs, breast tenderness and enlargement, mood
changes, changes in sex drive.
Uncommon: indigestion, being sick, flatulence,
gallstones and gallbladder disease, feeling dizzy,
migraine, vaginal thrush, increase in blood pressure,
Source: Medicines and Healthcare Products Regulatory Agency
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.